These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28746336)

  • 41. BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor.
    Gavai AV; Sher PM; Mikkilineni AB; Poss KM; McCann PJ; Girotra RN; Fisher LG; Wu G; Bednarz MS; Mathur A; Wang TC; Sun CQ; Slusarchyk DA; Skwish S; Allen GT; Hillyer DE; Frohlich BH; Abboa-Offei BE; Cap M; Waldron TL; George RJ; Tesfamariam B; Harper TW; Ciosek CP; Young DA; Dickinson KE; Seymour AA; Arbeeny CM; Washburn WN
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3041-4. PubMed ID: 11714606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
    Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.
    Pak MD; Fishman PH
    J Recept Signal Transduct Res; 1996; 16(1-2):1-23. PubMed ID: 8771528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hydrophobic amino acid cluster at the cytoplasmic end of transmembrane helix III modulates the coupling of the β(1)-adrenergic receptor to G(s).
    Hajjhussein H; Gardner LA; Fujii N; Anderson NM; Bahouth SW
    J Recept Signal Transduct Res; 2013 Apr; 33(2):79-88. PubMed ID: 23351074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural Basis of the Diversity of Adrenergic Receptors.
    Qu L; Zhou Q; Xu Y; Guo Y; Chen X; Yao D; Han GW; Liu ZJ; Stevens RC; Zhong G; Wu D; Zhao S
    Cell Rep; 2019 Dec; 29(10):2929-2935.e4. PubMed ID: 31801060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
    Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
    Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRM 1-mediated degradation and agonist-induced down-regulation of beta-adrenergic receptor mRNAs.
    Bai Y; Lu H; Machida CA
    Biochim Biophys Acta; 2006 Oct; 1763(10):1076-89. PubMed ID: 16997396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
    Brink CB; Wade SM; Neubig RR
    J Pharmacol Exp Ther; 2000 Aug; 294(2):539-47. PubMed ID: 10900230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
    Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
    J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
    Weitl N; Seifert R
    J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessments of cellular melatonin receptor signaling pathways: β-arrestin recruitment, receptor internalization, and impedance variations.
    Dupré C; Bruno O; Bonnaud A; Giganti A; Nosjean O; Legros C; Boutin JA
    Eur J Pharmacol; 2018 Jan; 818():534-544. PubMed ID: 29154938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of endogenous inverse agonists for G protein-coupled receptor 6.
    Shrader SH; Song ZH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1041-1045. PubMed ID: 31818461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor-I provokes functional antagonism and internalization of beta1-adrenergic receptors.
    Gavi S; Yin D; Shumay E; Wang HY; Malbon CC
    Endocrinology; 2007 Jun; 148(6):2653-62. PubMed ID: 17363461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S1P
    Birker-Robaczewska M; Bolli M; Rey M; de Kanter R; Kohl C; Lescop C; Boucher M; Poirey S; Steiner B; Nayler O
    Mol Pharmacol; 2018 Feb; 93(2):109-118. PubMed ID: 29203519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV; Okun I; Aladinskiy V; Ivanenkov Y; Koryakova A; Karapetyan R; Mitkin O; Salimov R; Ivashchenko A
    J Alzheimers Dis; 2017; 58(4):1043-1063. PubMed ID: 28550249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
    Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
    J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.